Across 3 studies (all review articles), 3 of 3 report beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on gut health, with a predominantly moderate effect size. No dose range, population, or study duration information is available from these sources.
Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 3 studies) — conclusions should be considered preliminary. None of the included studies reported statistical significance — effect may be smaller than the predominant direction suggests.
Bifidobacterium animalis subsp. lactis BB-12 has been associated with beneficial outcomes in various pathological and physiological conditions.
The review paper ... providing a foundation for future research aimed at optimizing the use of these technologies in clinical and industrial settings.
Bifidobacteria contribute to poultry health by modulating the gut microbiota, improving intestinal morphology and digestive enzyme activity, and regulating immune responses through cytokine balance and epithelial barrier reinforcement.